The European Partnership for Personalised Medicine (EP PerMed) will launch the Joint Transnational Call 2024 (JTC2024) to fund multinational innovative research projects in personalised medicine (PM).

The aim of this call is to fund research that fosters the identification or validation of targets for personalised medicine approaches. Applicants submitting a proposal to this call must combine the research on new and advanced targets with companion biomarker research (companion diagnostics).

The call will follow as a two-stage procedure:

The launch of the call is scheduled in the beginning of January 2024.

An open information day introducing the JTC2024 to the research community will be organised. More information (including the date and registration) will follow soon.

For more information visit: EP_PerMed-JTC2024-pre-announcement.pdf (eppermed.eu)

You can find all the news about Horizon Europe under the "Horizon Europe" banner on the Intranet.